ResearcherDong-A UniversityNo recent work listed
Young Bin Hong
Matched on ORCID iD 0000-0002-4333-3847; OpenAlex author ID A5101478663.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 5
2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 5
- Doxycycline potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer cells. Last author PMID 34354858↗
- Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.3892/ijo.2013.2229↗
- Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine. Co-author DOI 10.1111/jcmm.12101↗
- Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. First author DOI 10.1097/mpa.0b013e318230f71a↗
- Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. Co-author PMID 22399597↗
Closest collaborators
The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yeon-Sun Seong · 5 shared papers, 2012–2021
- Paper Doxycycline potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer cells. PMID 34354858↗
- Paper Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. DOI 10.3892/ijo.2013.2229↗
- Paper Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. DOI 10.1097/mpa.0b013e318230f71a↗
- Yong Weon Yi · 4 shared papers, 2012–2021
- Paper Doxycycline potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer cells. PMID 34354858↗
- Paper Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. DOI 10.3892/ijo.2013.2229↗
- Paper Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. DOI 10.1097/mpa.0b013e318230f71a↗
- Insoo Bae · 4 shared papers, 2012–2014
- Paper Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine. DOI 10.3892/ijo.2013.2229↗
- Paper Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. DOI 10.1097/mpa.0b013e318230f71a↗
- Paper Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. PMID 22399597↗
- Hong-Quan Duong · 2 shared papers, 2013–2014
- Yeon Jeong Kim · 2 shared papers, 2012–2013
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.